查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1836899

热原检测市场（按产品类型、测试方法、热原类型、最终用户和应用）—全球预测 2025-2032

Pyrogen Testing Market by Product Type, Test Method, Pyrogen Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，热原检测市场将成长至 34.3 亿美元，复合年增长率为 12.04%。

主要市场统计数据
基准年2024年 13.8亿美元
预计2025年 15.5亿美元
预测年份：2032年 34.3亿美元
复合年增长率（%） 12.04%

对影响生命科学公司热原检测实践的业务、监管和技术要求的权威介绍

热原检测是病人安全、法规遵循和分析创新的交会点。该领域历来以动物源性检测为根基，并稳步发展至体外替代方法和自动化分析平台，以降低差异性并提高通量，确保严格检测细菌内毒素和非内毒素热原，同时简化流程以满足紧迫的研发週期和日益严格的监管要求。

全球各地的监管机构都明确表达了对检测方法验证、试剂和对照品的可追溯性以及检测工作流程的稳健性的期望。因此，各机构优先投资于标准化检测方法、记录在案的品质系统和跨职能培训。同时，重组试剂和细胞化验分析等技术进步正在扩展品管和研究团队可用的套件，从而能够更特异性检测不同类型的热原。

因此，生物製药开发、合约测试和临床试验领域的领导者正在重新评估如何将测试模式与更广泛的品质架构相结合。这项措施为以下章节奠定了基础，提供了一个涵盖营运、监管和技术力量的框架，这些力量正在影响整个生态系统相关人员的短期和中期策略选择。

监管变化、检测创新、自动化和供应链弹性的整合正在从根本上重塑热原检测的执行和采购方式

监管环境的变化、科学创新和供应链重组正在改变热原检测的格局。首先，监管部门越来越重视与人体相关的检测方法和严格的检测方法验证，这推动了替代检测方法的采用，这些方法可以减少对动物源性试剂的依赖，并提高非内毒素热原的特异性。其次，检测化学和自动化技术的进步提高了实验室的通量，使各机构能够扩展其检测能力，同时提高可重复性和资料完整性。

第三，实验室工作流程的模组化加速了仪器、套件和软体的集成，使检测和品管系统之间的资料流更加无缝衔接。第四，试剂创新与下一代检测原理（例如重组C因子和基于细胞的单核细胞活化检测）的融合，为检测方法的差异化开闢了途径，从而能够应对复杂的产品矩阵。最后，供应链弹性已成为策略重点，相关人员正在多元化供应商关係，并重新评估筹资策略，以减轻中断的影响。

这些综合动态正在推动公司围绕与供应商的伙伴关係关係重组投资，这些供应商可以支援灵活性、监管协调、方法转移和培训以及持续的技术支援。累积效应是，市场奖励那些迅速采用经过验证的、与人相关的测试解决方案的公司，并惩罚那些推迟现代化测试组合的组织。

2025年美国关税调整将如何改变采购经济学、供应商策略以及设备和试剂采购的物流计划

2025年，美国不断演变的关税和贸易措施为依赖跨境采购仪器、套件、试剂和专业服务的机构带来了层层复杂性。关税调整影响了进口检测设备和关键试剂的到岸成本，迫使采购团队重新评估整体拥有成本、供应商选择标准和库存策略。一些实验室透过谈判签订长期合约来应对，而另一些实验室则透过多元化供应商，包括国内替代供应商和区域分销商，以保持营运的连续性。

政策环境也影响自动化系统和辅助设备的资本投资决策。由于进口关税增加了设备的初始成本，企业通常会推迟评估期，进行更严格的内部成本效益分析，并优先采购那些能够证明产量更高或监管优势更高的设备。这增加了对全面供应商支援的需求，包括安装、检验包装和现场服务协议，以降低高额初始投资的风险。

此外，製造商和经销商已调整合约条款和物流服务，以吸收或减轻关税带来的成本衝击。随着相关人员寻求可预测的供应链，本地仓储、重新包装和捆绑检验支援等附加价值服务已变得普遍。虽然关税不会改变选择检测方法的基本科学标准，但它正在加速筹资策略的务实调整，强调供应商的可靠性、售后服务支援和本地供应选择。

细分驱动的可操作分析揭示了产品类型、检测方法、热原分类、最终用户和应用的交叉点，从而影响了测试策略

从细分中获得的洞察揭示了产品、方法、热原类型、最终用户和应用维度之间的差异化动态，为商业和技术策略提供资讯。根据产品类型，对仪器、套件、试剂和服务的市场进行研究。进一步探索自动化系统、培养箱和 LAL 分析仪的仪器。探索固色剂、凝胶凝块和浊度剂的试剂套件。进一步探索对照、LAL 试剂和 RFC 试剂的试剂。更详细地探讨了咨询和测试服务的服务。这种以产品为导向的观点揭示了在自动化、试剂标准化和服务合约方面的投资将对营运可扩展性产生最大影响的地方。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 在生物製药生产流程中，越来越多地采用重组 C 因子检测法进行热原检测
  • 新兴的微流体LAL 检测平台可在需要时实现超快速内毒素定量
  • 将即时热原资料与电脑预测模型结合，实现主动品管
  • USP、EP 和 JP 之间的监管协调将推动全球市场热原检测方法的标准化
  • 开发多重热原和无菌检测，以简化大规模生技药品的放行检验流程
  • 增加对连续在线内毒素监测感测器的投资，以实现即时过程分析技术合规性

第六章 2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 热原检测市场（依产品类型）

  • 装置
    • 自动化系统
    • 培养箱
    • 鲎试剂分析仪
  • 套件
    • 显色
    • 凝胶凝块
    • 浊度计
  • 试剂
    • 控制
    • 鲎试剂
    • RFC试剂
  • 服务
    • 咨询服务
    • 测试服务

9. 热原检测市场（依测试方法）

  • 鲎血球裂解物
    • 显色
    • 凝胶凝块
    • 浊度计
  • 单核细胞活化试验
  • 重组因子C测定

第 10 章热原检测市场（按热原类型）

  • 细菌内毒素
  • 非内毒素热原
    • 真菌致热原
    • 霉浆菌热支原体
    • 病毒致热原

第 11 章热原检测市场（依最终用户）

  • 学术研究机构
  • 生技公司
  • 合约研究组织
  • 医院和诊所
  • 製药商

第12章热原检测市场（依应用）

  • 临床诊断
  • 药物开发
  • 品管
  • 研究

第十三章热原检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 14 章热原检测市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 15 章热原检测市场（按国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Thermo Fisher Scientific Inc.
    • Charles River Laboratories International, Inc.
    • Merck KGaA
    • Lonza Group AG
    • Eurofins Scientific SE
    • SGS SA
    • WuXi AppTec Co., Ltd.
    • Laboratory Corporation of America Holdings
    • Inotiv, Inc.
    • Pacific BioLabs, Inc.
Product Code: MRR-035AB9C0DA61

The Pyrogen Testing Market is projected to grow by USD 3.43 billion at a CAGR of 12.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.38 billion
Estimated Year [2025] USD 1.55 billion
Forecast Year [2032] USD 3.43 billion
CAGR (%) 12.04%

An authoritative primer on the operational, regulatory, and technological imperatives shaping contemporary pyrogen testing practices across life sciences organizations

Pyrogen testing sits at the intersection of patient safety, regulatory compliance, and analytical innovation. Historically rooted in animal-derived assays, the space has steadily evolved toward in vitro alternatives and automated analytical platforms that reduce variability and increase throughput. Today, laboratories and manufacturers face a dual mandate: to ensure rigorous detection of bacterial endotoxins and non-endotoxin pyrogens while simultaneously streamlining processes to meet compressed development timelines and heightened regulatory scrutiny.

Regulatory agencies globally have articulated expectations that emphasize method validation, traceability of reagents and controls, and demonstrable robustness of testing workflows. As a result, organizations have prioritized investments in standardized assays, documented quality systems, and cross-functional training. At the same time, technological advances such as recombinant reagents and cell-based assays have expanded the toolkit available to quality control and research teams, enabling more specific detection of diverse pyrogen classes.

Consequently, leaders in biopharmaceutical development, contract testing, and clinical laboratories are reassessing how testing modalities integrate with broader quality architectures. This introduction lays the groundwork for subsequent sections by framing the operational, regulatory, and technological forces that are shaping immediate and medium-term strategic choices for stakeholders across the ecosystem.

The confluence of regulatory pivoting, assay innovation, automation, and supply chain resilience that is radically reshaping how pyrogen testing is executed and procured

The landscape of pyrogen testing is undergoing transformative shifts driven by regulatory change, scientific innovation, and supply chain realignment. First, regulatory emphasis on human-relevant assays and rigorous method validation has catalyzed adoption of alternative test methods that reduce reliance on animal-derived reagents and offer greater specificity for non-endotoxin pyrogens. Second, advances in assay chemistry and automation have expanded laboratory throughput, allowing organizations to scale testing capacity while improving reproducibility and data integrity.

Third, the modularization of laboratory workflows has accelerated the integration of instruments, kits, and software, enabling more seamless data flows between testing and quality management systems. Fourth, the convergence of reagent innovation and next-generation detection principles - including recombinant factor C and cell-based monocyte activation tests - has created pathways for assay differentiation that can address complex product matrices. Finally, supply chain resilience has ascended as a strategic priority, with stakeholders diversifying supplier relationships and re-evaluating sourcing strategies to mitigate disruptions.

Together, these dynamics are prompting companies to reframe their investments around flexibility, regulatory alignment, and vendor partnerships that can support method transfer, training, and sustained technical support. The cumulative effect is a market that rewards nimble adopters of validated, human-relevant testing solutions and penalizes organizations that delay modernization of their testing portfolios.

How 2025 United States tariff adjustments have reshaped procurement economics, supplier strategies, and logistical planning for instrumentation and reagent sourcing

In 2025, evolving tariff policies and trade measures in the United States have introduced a layer of complexity for organizations that rely on cross-border procurement of instruments, kits, reagents, and specialized services. Tariff adjustments have affected the landed cost of imported laboratory equipment and critical reagents, prompting procurement teams to reassess total cost of ownership, vendor selection criteria, and inventory strategies. Some laboratories have responded by negotiating longer-term contracts, while others have diversified suppliers to include domestic alternatives or regional distributors to preserve continuity of operations.

The policy environment has also influenced decisions around capital expenditures for automated systems and ancillary equipment. When import duties elevate upfront equipment costs, organizations often extend evaluation timelines to perform more rigorous internal cost-benefit analyses and to prioritize purchases that deliver demonstrable throughput gains or regulatory advantages. This, in turn, has increased demand for comprehensive vendor support, including installation, validation packages, and local service agreements that de-risk the higher initial outlay.

Moreover, manufacturers and distributors have adapted contractual terms and logistical offerings to absorb or mitigate tariff-driven cost shocks. Value-added services, such as local warehousing, repackaging, or bundled validation support, have become more common as stakeholders seek predictable supply lines. While tariffs have not altered the fundamental scientific criteria for selecting testing modalities, they have accelerated a pragmatic rebalancing of sourcing strategies that emphasizes supplier reliability, after-sales support, and regional supply options.

Actionable segmentation-driven analysis revealing where product types, assay methods, pyrogen classifications, end users, and applications intersect to influence testing strategies

Insights from segmentation reveal differentiated dynamics across product, method, pyrogen type, end user, and application dimensions that inform commercial and technical strategies. Based on Product Type, market is studied across Instruments, Kits, Reagents, and Services. The Instruments is further studied across Automated Systems, Incubators, and LAL Analyzers. The Kits is further studied across Chromogenic, Gel Clot, and Turbidimetric. The Reagents is further studied across Controls, LAL Reagents, and RFC Reagents. The Services is further studied across Consulting Services and Testing Services. This product-oriented view highlights where investments in automation, reagent standardization, and service contracts are most impactful for operational scalability.

Based on Test Method, market is studied across Limulus Amebocyte Lysate, Monocyte Activation Test, and Recombinant Factor C Assay. The Limulus Amebocyte Lysate is further studied across Chromogenic, Gel Clot, and Turbidimetric. Method-level segmentation underscores the trade-offs between legacy familiarity and the technical advantages of newer, human-relevant assays, and helps stakeholders prioritize validation pathways and method transfer activities.

Based on Pyrogen Type, market is studied across Bacterial Endotoxin and Non-Endotoxin Pyrogens. The Non-Endotoxin Pyrogens is further studied across Fungal Pyrogens, Mycoplasma Pyrogens, and Viral Pyrogens. This distribution of pyrogen types clarifies the necessity for tailored detection approaches and contingency testing strategies for complex biologic matrices. Based on End User, market is studied across Academic & Research Institutes, Biotechnology Companies, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical Manufacturers. This end-user lens demonstrates how user requirements for throughput, regulatory support, and technical training vary across segments. Based on Application, market is studied across Clinical Diagnostics, Drug Development, Quality Control, and Research. Application-based segmentation draws attention to differential validation burdens and reporting needs that influence instrument selection, kit format preference, and third-party service utilization.

Interpreting these segmentation layers together enables decision-makers to align procurement, validation investments, and supplier partnerships with the nuanced requirements of each testing context. For example, organizations prioritizing high-throughput quality control workflows will weigh automated instruments and robust reagent controls more heavily, whereas academic labs and early-stage developers may prioritize flexible kit formats and method versatility.

Comparative regional analysis explaining how geographic regulatory environments, supply chains, and service ecosystems drive divergent adoption patterns in pyrogen testing

Regional considerations materially shape technology adoption, regulatory alignment, and supply chain architectures for pyrogen testing. In the Americas, centralized regulatory frameworks and a concentration of large pharmaceutical operations have supported rapid uptake of automation and validated alternative assays, with an emphasis on integration into established quality systems and clear documentation for regulatory inspections. By contrast, Europe, Middle East & Africa exhibits heterogeneity in regulatory approaches and infrastructure maturity; this region places a premium on assay flexibility, reagent standardization, and vendor partnerships capable of supporting local validations and multilingual technical services.

In the Asia-Pacific region, a combination of high-volume manufacturing, growing biotech innovation hubs, and a drive toward self-reliance in critical reagent supply has accelerated adoption of both proven and emerging testing modalities. Regional manufacturing centers are increasingly focused on building in-house capabilities for testing and supporting method transfers to global sites. Across all regions, logistical considerations, trade policies, and local service footprints influence procurement timelines and choices of instrument and reagent partners.

Understanding these geographic dynamics is essential for organizations designing global testing strategies, because regulatory expectations, vendor service models, and supply chain resilience vary substantially by region. Companies that harmonize validation strategies, invest in regional technical support, and adapt inventory policies to local logistics will reduce operational risk and accelerate time-to-qualification for new methods and products.

Sophisticated competitive landscape analysis highlighting how instrument vendors, reagent manufacturers, and specialized service providers are redefining value propositions in pyrogen testing

Competitive dynamics in the pyrogen testing ecosystem reflect a mix of established instrument suppliers, specialized reagent manufacturers, and niche service providers that together shape procurement and validation choices. Instrument suppliers differentiate through automation, integration capabilities, and lifecycle service agreements that reduce operational downtime. Reagent manufacturers compete on reagent consistency, traceability, and compatibility with multiple assay formats, while specialized kit providers focus on ease-of-use and rapid deployment for diverse laboratory settings.

Service providers, including testing laboratories and consulting firms, play a critical role in method validation, transfer, and regulatory submission support. Their ability to deliver robust validation packages, cross-validation data, and training accelerates adoption of alternative assays and supports quality systems during inspections. Partnerships between reagent vendors and service providers create bundled offerings that reduce technical friction and shorten implementation timelines.

Innovators in assay chemistry and cell-based detection are gaining commercial traction by offering alternatives that address non-endotoxin pyrogen detection and complex biologic matrices. Strategic collaboration between manufacturers, contract laboratories, and end users is increasingly common, enabling co-development of assays, shared validation efforts, and pilot programs that de-risk scale-up. Organizations evaluating vendors should assess not only technical performance metrics but also the depth of documentation, training resources, and local support networks that collectively determine long-term success.

Practical, prioritized recommendations for laboratory managers and corporate leaders to validate methods, diversify suppliers, and build resilient pyrogen testing operations

Industry leaders should adopt a strategy that balances scientific rigor, operational resilience, and vendor ecosystem optimization. First, prioritize method validation plans that include head-to-head comparisons between legacy and emerging assays and that document equivalency across representative product matrices. Second, formalize supplier qualification criteria that evaluate reagent traceability, installation and validation support for instruments, and local service capabilities to minimize downtime.

Third, invest in modular automation where possible to enable scalable throughput without entangling laboratories in single-vendor lock-in. Fourth, develop inventory and procurement playbooks that address tariff variability and seasonal supply risks, including options for regional sourcing and aggregate contracting across business units. Fifth, engage early with regulatory stakeholders to align submission strategies for alternative assays and to clarify expectations for validation documentation.

Finally, cultivate cross-functional training programs that bring quality, R&D, and operations teams into shared ownership of testing outcomes. These steps will increase organizational agility, reduce time required to qualify new methods, and strengthen the defensibility of testing strategies during regulatory review.

Transparent mixed-methods research approach combining expert interviews, technical literature review, and supplier documentation analysis to derive reproducible insights

This research employed a mixed-methods approach that integrated primary interviews, technical literature review, and supplier documentation analysis to produce actionable insights. Subject-matter experts from quality control laboratories, regulatory affairs, and assay development were engaged to capture experiential knowledge about method transfer challenges, validation expectations, and service provider capabilities. The literature review focused on peer-reviewed studies, regulatory guidance documents, and white papers that describe assay performance characteristics and human-relevant testing strategies.

Supplier documentation and publicly available technical bulletins were analyzed to assess instrument capabilities, reagent compositions, and available validation packages. Where appropriate, comparative analysis of assay principles and workflow integration was conducted to evaluate practical implementation considerations. Data synthesis emphasized recurring themes and divergences in stakeholder perspectives rather than quantitative market aggregates, and the methodology prioritized reproducibility by documenting interview protocols, source categorizations, and criteria for inclusion.

Limitations of the approach include variability in public disclosure practices among vendors and the evolving nature of regulatory guidance. To mitigate these constraints, the study triangulated findings across multiple independent sources and provided clear annotations where interpretations required expert judgment.

Concise strategic conclusions emphasizing validation rigor, supplier resilience, and integrated governance as pillars of effective pyrogen testing programs

In closing, the trajectory of pyrogen testing reflects a steady shift toward assays and workflows that deliver human-relevant sensitivity, operational efficiency, and regulatory defensibility. Stakeholders who align validation strategies, supplier relationships, and automation investments with these priorities will be best positioned to manage the technical and commercial complexities inherent to biologic and pharmaceutical testing. Moreover, a proactive approach to supply chain planning and vendor qualification can buffer operations against tariff-related cost pressures and logistical disruptions.

Decision-makers must view pyrogen testing not as an isolated laboratory function but as an integral component of product quality and patient safety frameworks. Integrating cross-functional governance, investing in scalable technologies, and engaging service partners for validation support will materially reduce time and uncertainty when implementing new testing modalities. The insights contained in the preceding sections aim to equip leadership teams with the strategic perspective necessary to prioritize investments and to operationalize robust, future-ready testing programs.

Taken together, these conclusions underscore the importance of purposeful modernization, disciplined validation, and pragmatic supplier management as the cornerstones of a resilient pyrogen testing strategy.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing adoption of recombinant Factor C assays for pyrogen detection in biopharmaceutical manufacturing workflows
  • 5.2. Emergence of microfluidic LAL testing platforms enabling ultra rapid endotoxin quantification at point of need
  • 5.3. Integration of in silico predictive models with real time pyrogen data for proactive quality control
  • 5.4. Regulatory harmonization drive between USP EP and JP to standardize pyrogen test methods across global markets
  • 5.5. Development of multiplex pyrogen and sterility assays to streamline biologics release testing processes at scale
  • 5.6. Growing investment in continuous online endotoxin monitoring sensors for real time process analytical technology compliance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pyrogen Testing Market, by Product Type

  • 8.1. Instruments
    • 8.1.1. Automated Systems
    • 8.1.2. Incubators
    • 8.1.3. LAL Analyzers
  • 8.2. Kits
    • 8.2.1. Chromogenic
    • 8.2.2. Gel Clot
    • 8.2.3. Turbidimetric
  • 8.3. Reagents
    • 8.3.1. Controls
    • 8.3.2. LAL Reagents
    • 8.3.3. RFC Reagents
  • 8.4. Services
    • 8.4.1. Consulting Services
    • 8.4.2. Testing Services

9. Pyrogen Testing Market, by Test Method

  • 9.1. Limulus Amebocyte Lysate
    • 9.1.1. Chromogenic
    • 9.1.2. Gel Clot
    • 9.1.3. Turbidimetric
  • 9.2. Monocyte Activation Test
  • 9.3. Recombinant Factor C Assay

10. Pyrogen Testing Market, by Pyrogen Type

  • 10.1. Bacterial Endotoxin
  • 10.2. Non-Endotoxin Pyrogens
    • 10.2.1. Fungal Pyrogens
    • 10.2.2. Mycoplasma Pyrogens
    • 10.2.3. Viral Pyrogens

11. Pyrogen Testing Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Hospitals & Clinics
  • 11.5. Pharmaceutical Manufacturers

12. Pyrogen Testing Market, by Application

  • 12.1. Clinical Diagnostics
  • 12.2. Drug Development
  • 12.3. Quality Control
  • 12.4. Research

13. Pyrogen Testing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Pyrogen Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Pyrogen Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Charles River Laboratories International, Inc.
    • 16.3.3. Merck KGaA
    • 16.3.4. Lonza Group AG
    • 16.3.5. Eurofins Scientific SE
    • 16.3.6. SGS SA
    • 16.3.7. WuXi AppTec Co., Ltd.
    • 16.3.8. Laboratory Corporation of America Holdings
    • 16.3.9. Inotiv, Inc.
    • 16.3.10. Pacific BioLabs, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY AUTOMATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PYROGEN TESTING MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PYROGEN TESTING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PYROGEN TESTING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTROLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PYROGEN TESTING MARKET SIZE, BY LAL REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PYROGEN TESTING MARKET SIZE, BY RFC REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONSULTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PYROGEN TESTING MARKET SIZE, BY TESTING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C ASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PYROGEN TESTING MARKET SIZE, BY BACTERIAL ENDOTOXIN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PYROGEN TESTING MARKET SIZE, BY FUNGAL PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PYROGEN TESTING MARKET SIZE, BY MYCOPLASMA PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL PYROGEN TESTING MARKET SIZE, BY VIRAL PYROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL PYROGEN TESTING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL PYROGEN TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL PYROGEN TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL PYROGEN TESTING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL PYROGEN TESTING MARKET SIZE, BY DRUG DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL PYROGEN TESTING MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL PYROGEN TESTING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 297. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA PYROGEN TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY KITS, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY KITS, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY REAGENTS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST METHOD, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2018-2024 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMEBOCYTE LYSATE, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PYROGEN TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY NON-ENDOTOXIN PYROGENS, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EA